Production of iodine-125 in nuclear reactors

dc.contributor.authorZEITUNI, CARLOS A.pt_BR
dc.contributor.authorROSTELATO, MARIA E.C.M.pt_BR
dc.contributor.authorJAE-SON, KWANGpt_BR
dc.contributor.authorLEE, JUN S.pt_BR
dc.contributor.authorCOSTA, OSVALDO L.pt_BR
dc.contributor.authorMOURA, JOÃO A.pt_BR
dc.contributor.authorFEHER, ANSELMOpt_BR
dc.contributor.authorMOURA, EDUARDO S.pt_BR
dc.contributor.authorSOUZA, CARLA D.pt_BR
dc.contributor.authorMATTOS, FABIO R.pt_BR
dc.contributor.authorPELEIAS JUNIOR, FERNANDO S.pt_BR
dc.contributor.authorKARAM JUNIOR, DIBpt_BR
dc.contributor.editorDUDALA, JOANNApt_BR
dc.contributor.editorSTEGOWSKI, ZDZISLAWpt_BR
dc.coverageInternacionalpt_BR
dc.creator.eventoINTERNATIONAL CONFERENCE ON DEVELOPMENT AND APPLICATIONS OF NUCLEAR TECHNOLOGIESpt_BR
dc.date.accessioned2022-10-27T18:59:10Z
dc.date.available2022-10-27T18:59:10Z
dc.date.eventoSeptember 11-14, 2011pt_BR
dc.description.abstractCancer is one of the worst illnesses in the world and one of the major causes of death in Brazil [1,2]. For this reason, the Nuclear Energy National Commission (CNEN) started a project to produce some medical radioisotopes to treat cancer. One of the main products is the iodine-125 seeds [3]. This iodine seed can be used to treat several kinds of cancer: prostate, lung, eye, brain. As Brazil will construct a new reactor to produce radioisotopes, it is necessary define how the iodine-125 production will carry out [4,5]. The main reaction of this production is the irradiation of the enriched xenon-124 in gaseous form. Xe-124 changed to Iodine-125 by neutron capture following in two decays: Xe-124 (n, y) —• Xe-125m (57s) —• I- 125 or Xe-124 (n, y) —• Xe-125 (19.9 h) —• 1-125. However the production in reactors is the most common technique used, there is one disadvantage to use it: the production of iodine- 126 after several hours of irradiation. Iodine-126 has a half life of 13.1 days and it has some usefulness emitters for medical uses. Iodine-126 is considered a contamination [6]. For all these reasons, the IPEN/CNEN-SP research group decided for two techniques of production: in batch or continuous system. The production in batch consists in a sealed capsule that is placed in the reactor core for around 64 hours. In this type of production, some iodine-126 is produced and a certain quantity of Xe-124 is not activated. Normally, it needs to wait around 5 to 7 iodine-126 half-lives to guarantee the decrease of the activity of the contamination. This time will make Iodine-125 with only 50% till 34% of the initial production. The second technique is the continuous production using a cryogenic system. This technique consists in two capsules: one inside the reactor core and the second one out of the neutron flux. These two capsules will be linked with two cryogenic pumps to guarantee that all iodine-125 produced in the core will be take off the reactor core. The great disadvantage of this technique is the using of two positions in the core of the reactor. Brazil will have only one radioisotope reactor producing. And like there is a huge quantity of materials to be produced, it is not a guarantee the position in the reactor for this production. Besides of that the seeds production in Brazil is only 3000 per month, which demands around 3.5 Ci per month. The batch production produces a low quantity per reactor cycle of iodine-125, but this low quantity can be more than that [2,3].pt_BR
dc.event.siglaNUTECHpt_BR
dc.format.extent149-150pt_BR
dc.identifier.citationZEITUNI, CARLOS A.; ROSTELATO, MARIA E.C.M.; JAE-SON, KWANG; LEE, JUN S.; COSTA, OSVALDO L.; MOURA, JOÃO A.; FEHER, ANSELMO; MOURA, EDUARDO S.; SOUZA, CARLA D.; MATTOS, FABIO R.; PELEIAS JUNIOR, FERNANDO S.; KARAM JUNIOR, DIB. Production of iodine-125 in nuclear reactors: advantages and disadvantages of production in batch or continuous production in cryogenic system. In: DUDALA, JOANNA (ed.); STEGOWSKI, ZDZISLAW (ed.). In: INTERNATIONAL CONFERENCE ON DEVELOPMENT AND APPLICATIONS OF NUCLEAR TECHNOLOGIES, September 11-14, 2011, Krakow, Poland. <b>Abstract...</b> Krakow, Poland: Faculty of Physics and Applied Computer Science, AGH University of Science and Technology, 2011. p. 149-150. Disponível em: http://repositorio.ipen.br/handle/123456789/33342.
dc.identifier.orcid0000-0001-5989-7287pt_BR
dc.identifier.orcid0000-0003-2943-6097pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5054-0799
dc.identifier.orcidhttp://orcid.org/0000-0003-1335-8864
dc.identifier.orcidhttps://orcid.org/0000-0003-2943-6097
dc.identifier.orcidhttps://orcid.org/0000-0002-7303-6720
dc.identifier.urihttp://repositorio.ipen.br/handle/123456789/33342
dc.localKrakow, Polandpt_BR
dc.local.eventoKrakow, Polandpt_BR
dc.publisherFaculty of Physics and Applied Computer Science, AGH University of Science and Technologypt_BR
dc.rightsopenAccesspt_BR
dc.subjectcryogenics
dc.subjectiodine 125
dc.subjectisotope production
dc.subjectisotope production reactors
dc.subjectnuclear medicine
dc.subjectradiopharmaceuticals
dc.titleProduction of iodine-125 in nuclear reactorspt_BR
dc.typeResumo de eventos científicospt_BR
dspace.entity.typePublication
ipen.autorJOÃO AUGUSTO MOURA
ipen.autorCARLA DARUICH DE SOUZA
ipen.autorFABIO RODRIGUES DE MATTOS
ipen.autorFERNANDO DOS SANTOS PELEIAS JUNIOR
ipen.autorEDUARDO SANTANA DE MOURA
ipen.autorANSELMO FEHER
ipen.autorOSVALDO LUIZ DA COSTA
ipen.autorMARIA ELISA CHUERY MARTINS ROSTELATO
ipen.autorCARLOS ALBERTO ZEITUNI
ipen.codigoautor6611
ipen.codigoautor7717
ipen.codigoautor9366
ipen.codigoautor9761
ipen.codigoautor5860
ipen.codigoautor786
ipen.codigoautor669
ipen.codigoautor7
ipen.codigoautor944
ipen.contributor.ipenauthorJOÃO AUGUSTO MOURA
ipen.contributor.ipenauthorCARLA DARUICH DE SOUZA
ipen.contributor.ipenauthorFABIO RODRIGUES DE MATTOS
ipen.contributor.ipenauthorFERNANDO DOS SANTOS PELEIAS JUNIOR
ipen.contributor.ipenauthorEDUARDO SANTANA DE MOURA
ipen.contributor.ipenauthorANSELMO FEHER
ipen.contributor.ipenauthorOSVALDO LUIZ DA COSTA
ipen.contributor.ipenauthorMARIA ELISA CHUERY MARTINS ROSTELATO
ipen.contributor.ipenauthorCARLOS ALBERTO ZEITUNI
ipen.date.recebimento22-10
ipen.event.datapadronizada2011pt_BR
ipen.identifier.ipendoc26660pt_BR
ipen.notas.internasAbstractpt_BR
ipen.subtituloadvantages and disadvantages of production in batch or continuous production in cryogenic systempt_BR
ipen.type.genreResumo
relation.isAuthorOfPublication6a96a2fe-6eb6-488b-bd21-ac2b4e1335a3
relation.isAuthorOfPublication866434dc-2634-4567-8b4b-04e5ce06bf04
relation.isAuthorOfPublication072f386b-7620-48dd-8359-f6f518c6c115
relation.isAuthorOfPublication66c35c1b-6a0c-4f5d-8379-92a35c78f478
relation.isAuthorOfPublicationfa668b29-92e1-43e8-b9db-5c151ab7d93d
relation.isAuthorOfPublication52268eaa-9747-4444-b301-7e33219b912c
relation.isAuthorOfPublication61396bf8-f804-4323-a509-a1e70ffe4a3c
relation.isAuthorOfPublicationda77b491-04ff-4c68-aa65-dead9208a48c
relation.isAuthorOfPublication02421b96-adef-4759-b25e-67d4759aa676
relation.isAuthorOfPublication.latestForDiscovery02421b96-adef-4759-b25e-67d4759aa676
sigepi.autor.atividadePELEIAS JUNIOR, FERNANDO S.:9761:-1:Npt_BR
sigepi.autor.atividadeMATTOS, FABIO R.:9366:-1:Npt_BR
sigepi.autor.atividadeSOUZA, CARLA D.:7717:230:Npt_BR
sigepi.autor.atividadeMOURA, EDUARDO S.:5860:230:Npt_BR
sigepi.autor.atividadeFEHER, ANSELMO:786:230:Npt_BR
sigepi.autor.atividadeMOURA, JOÃO A.:6611:230:Npt_BR
sigepi.autor.atividadeCOSTA, OSVALDO L.:669:230:Npt_BR
sigepi.autor.atividadeROSTELATO, MARIA E.C.M.:7:230:Npt_BR
sigepi.autor.atividadeZEITUNI, CARLOS A.:944:230:Spt_BR

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
26660.pdf
Tamanho:
36.22 KB
Formato:
Adobe Portable Document Format
Descrição:

Licença do Pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: